Enhancer ID: | E_02_0115 |
Species: | human |
Position : | chr19:33297251-33299251 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 31141090 |
Enhancer experiment: | PCR |
Enhancer experiment description: | Moreover, this translocation is detected in 50% of T-ALL patients with gamma/delta T cell receptor rearrangement, frequently associated with low expression of transcription factor CCAAT/enhancer-binding protein alpha (CEBPA). |
Target gene : | CEBPA(C/ebpalpha,CBF-A,Cebp) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Moreover, this translocation is detected in 50% of T-ALL patients with gamma/delta T cell receptor rearrangement, frequently associated with low expression of transcription factor CCAAT/enhancer-binding protein alpha (CEBPA). |
TF name : | -- |
TF experiment: | PCR |
TF experiment description: | Moreover, this translocation is detected in 50% of T-ALL patients with gamma/delta T cell receptor rearrangement, frequently associated with low expression of transcription factor CCAAT/enhancer-binding protein alpha (CEBPA). |
Enhancer function : | Moreover, this translocation is detected in 50% of T-ALL patients with gamma/delta T cell receptor rearrangement, frequently associated with low expression of transcription factor CCAAT/enhancer-binding protein alpha (CEBPA). |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Moreover, this translocation is detected in 50% of T-ALL patients with gamma/delta T cell receptor rearrangement, frequently associated with low expression of transcription factor CCAAT/enhancer-binding protein alpha (CEBPA). |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|